The Food and Drug Administration on Wednesday approved Eisai's epilepsy drug Fyompa as a primary treatment for partial-onset seizures in epileptic patients 12 years or older.

Oxcarbazepine has been found to reduce seizure frequency of newly diagnosed and refractory partial seizures in clinical practice. 11,12 A newer drug, vigabatrin, for refractory partial epilepsy ...

Lacosamide (LCM) is an antiepileptic drug recommended as adjunctive therapy for partial-onset seizures. This study evaluates the efficacy of LCM as adjunctive therapy in placebo-controlled trials.

“After a round of tests, it was determined that the cause of the brief pause in my speech was a complex partial seizure,” U.S. Rep. John Larson said.

Mangalore: Autoimmune encephalitis, a condition in which the body’s immune system mistakenly attacks healthy brain tissue, ...

Results from immunohistochemistry, Western blot, whole-cell patch-clamp recording, and in vivo seizure monitoring showed that LM treatment increased the number of perisomatic PV interneuronal synapses ...